Software Healthcare Sector

Hydreight Technologies

Market Cap: CA$214.1m

Operates in the digital health technology sector in the United States.

Streamex

Market Cap: US$154.5m

A medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States.

Semnur Pharmaceuticals

Market Cap: US$154.3m

A late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.

NRx Pharmaceuticals

Market Cap: US$154.0m

A clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States.

EBR Systems

Market Cap: AU$214.7m

Develops implantable systems for wireless tissue stimulation.

Kazia Therapeutics

Market Cap: US$153.2m

Operates as an oncology-focused biotechnology company in Israel.

BLS Pharmaceuticals

Market Cap: AU$213.9m

Manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan.

Cypherpunk Technologies

Market Cap: US$153.0m

A privacy technology company, implements a digital asset strategy anchored by Zcash in the United States.

Owlet

Market Cap: US$152.0m

Provides digital parenting solutions in the United States, the United Kingdom, and internationally.

Aardvark Therapeutics

Market Cap: US$149.3m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

EKF Diagnostics Holdings

Market Cap: UK£109.3m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.

Inogen

Market Cap: US$148.9m

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

Milestone Pharmaceuticals

Market Cap: US$148.7m

A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.

Connect Biopharma Holdings

Market Cap: US$148.6m

Operates as a clinical-stage biopharmaceutical company in the United States.

Spruce Biosciences

Market Cap: US$148.2m

A biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

KORU Medical Systems

Market Cap: US$148.2m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

Tiziana Life Sciences

Market Cap: US$147.4m

Engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally.

LENZ Therapeutics

Market Cap: US$147.0m

Operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Equillium

Market Cap: US$146.5m

A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States.

OptimizeRx

Market Cap: US$145.2m

Operates as a digital healthcare technology company.

MaxCyte

Market Cap: US$142.4m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Aroa Biosurgery

Market Cap: AU$198.9m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Stereotaxis

Market Cap: US$142.3m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

Insight Molecular Diagnostics

Market Cap: US$142.0m

Operates as a precision diagnostics company in the United States and internationally.

Quanterix

Market Cap: US$141.4m

A life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

Dimerix

Market Cap: AU$186.1m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

INSPECS Group

Market Cap: UK£97.6m

Designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia.

Apyx Medical

Market Cap: US$131.4m

An energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.

Nyrada

Market Cap: AU$182.8m

A clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia.

Optiscan Imaging

Market Cap: AU$182.7m

Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States.

ProMIS Neurosciences

Market Cap: US$130.1m

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.

Cibus

Market Cap: US$129.9m

An agricultural biotechnology company that develops and licenses gene-edited plant traits.

BioSyent

Market Cap: CA$179.6m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

TuHURA Biosciences

Market Cap: US$127.5m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

ADC Therapeutics

Market Cap: US$127.2m

Provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States.

Black Diamond Therapeutics

Market Cap: US$127.0m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.